USFDA completes inspection at Alkem Laboratories’ St Louis facility

30 Oct 2017 Evaluate

The US Food & Drug Administration (USFDA) has completed the inspection at Alkem Laboratories’ St Louis facility. The regulator had conducted an inspection at the company’s manufacturing facility located at St Louis, USA from October 23, 2017 to October 27, 2017. At the end of the inspection, no Form 483 was issued.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.


Alkem Laboratories Share Price

5145.00 77.35 (1.53%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.